The technology vendor is going outside the company to hire PNC vet Michael Lyons to replace Trump Administration-bound Frank Bisignano, leaving the Pittsburgh-bank without its heir apparent for the ...
Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...